This guideline includes statements and recommendations based on available, high-level evidence about the use of sentinel node biopsy in women with early (operable) breast cancer. The guideline aims to provide health professionals with information to assist in making management recommendations for improved patient outcomes. NBOCC* also develops information specifically for consumers about early breast cancer diagnosis and treatment options.

A clinical practice guideline developed by National Breast And Ovarian Cancer Centre (NBOCC)*

This document supplements guideline recommendation 9 about axillary node dissection (page 8) and information about sentinel node biopsy (page 57) contained in the National Breast Cancer Centre (NBCC)* Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.

National Breast and Ovarian Cancer Centre (NBOCC)* has recommendations about staging and management of the axilla in early breast cancer to supplement chapter 4.4 (pages 55-59) of the NBCC Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.

Incorporates published evidence to July 2007

Endorsed by:

• Breast Cancer Network Australia
• The Faculty of Radiation Oncology - The Royal Australian and New Zealand College of Radiologists
• The Royal College of Pathologists of Australia (RCPA)
• The Royal Australasian College of Surgeons

ISBN Print: 978-1-74127-112-6
ISBN Online: 978-1-74127-113-3
CIP: 618.190758
© Cancer Australia 2011

* In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.